HysensBio
PrivateLast Round
Private Equity
Feb 1, 2026
Est. Valuation
$75.9M
Total Funding Raised
$21.57M
Company Overview
HysensBio is a drug discovery company that develops dental treatment technology using a cell activation platform to provide therapies for dentin hypersensitivity and dental caries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HysensBio Comparables
Compare HysensBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mintech-Bio | 78% | |
| Stemden | 77% | |
| Toregem BioPharma | 74% |
HysensBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 1, 2026 | ||||
| VC Round | Jul 24, 2023 | ||||
| Series C | May 7, 2021 | ||||
| Series B | May 29, 2019 | ||||
| Series A | Mar 1, 2018 |
HysensBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DAYLI Partners | Series B |
| Korea Investment Partners | Private Equity, Series B, Series A, Series C |
| KB Investment | Private Equity, VC Round |
| DS Asset Management | Series C, VC Round |
| Timefolio Asset Management | Series B, Series C |
| KTB Ventures | Series C |
| Daol Investment | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Won Pitch Competition at ADA Forsyth dentech 2025.
- Jan 1, 2025
Attended the Pitch Competition at ADA Forsyth dentech 2025.
HysensBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about HysensBio's valuation, stock price, and market status.
Is HysensBio a public or private company?
HysensBio is a private company.
What is the current stock price of HysensBio?
HysensBio is a private company with no public stock price. No recent secondary market data is available.
How much is HysensBio worth (valuation)?
HysensBio's valuation is estimated at $77.8M based on funding round data.
Can I buy HysensBio stock?
HysensBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was HysensBio's last funding round?
HysensBio's most recent funding round was VC Round on July 12, 2023.
Who are the main investors in HysensBio?
Key investors in HysensBio include Korea Investment Partners.
Will HysensBio IPO soon?
No public IPO plans have been announced for HysensBio.
How can I track HysensBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HysensBio's secondary market activity and sign up for updates.